Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.5 GBX | -3.77% | +6.25% | +64.52% |
18/04 | Renalytix chief business officer to become president | AN |
18/04 | Renalytix Names Chief Business Officer as President | MT |
Sales 2024 * | 4M 334M | Sales 2025 * | 18M 1.5B | Capitalization | 49.26M 4.11B |
---|---|---|---|---|---|
Net income 2024 * | -35M -2.92B | Net income 2025 * | -26M -2.17B | EV / Sales 2024 * | 12.3 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.74 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.42% |
Latest transcript on Renalytix Plc
1 day | -3.77% | ||
1 week | +6.25% | ||
Current month | +18.60% | ||
1 month | -10.53% | ||
3 months | +148.78% | ||
6 months | -33.77% | ||
Current year | +64.52% |
Managers | Title | Age | Since |
---|---|---|---|
James McCullough
FOU | Founder | 56 | 15/18/15 |
James Sterling
DFI | Director of Finance/CFO | 54 | 15/18/15 |
Howard Doran
PSD | President | 63 | 01/23/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Levangie
BRD | Director/Board Member | 73 | 30/21/30 |
Chairman | 72 | 15/18/15 | |
James McCullough
FOU | Founder | 56 | 15/18/15 |
Date | Price | Change | Volume |
---|---|---|---|
09/24/09 | 25.5 | -3.77% | 524,560 |
08/24/08 | 26.5 | 0.00% | 98,300 |
07/24/07 | 26.5 | -3.64% | 400,630 |
03/24/03 | 27.5 | -1.79% | 326,997 |
02/24/02 | 28 | +16.67% | 1,242,620 |
Delayed Quote London S.E., May 09, 2024 at 09:05 pm IST
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+64.52% | 51.11M | |
-15.43% | 18.51B | |
-40.81% | 2.85B | |
+19.34% | 1.95B | |
+2.22% | 1.72B | |
+28.27% | 1.26B | |
-9.56% | 1.02B | |
-16.29% | 950M | |
+0.07% | 777M | |
-22.49% | 643M |
- Stock Market
- Equities
- RENX Stock